Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Brief group education program for adults with ADHD

Official title: The Effect of a Brief Educational Intervention for Adults With ADHD: a Randomized Control Trial

Run by St. Olavs Hospital · NCT06284655 · Data updated 2026-11-12

This project will test whether a short group education program added to usual care helps adults with ADHD feel more confident, better informed, and more satisfied with their treatment.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorSt. Olavs Hospital
Academic / other
Locations1 site (Trondheim)
StatusRecruiting
StartedFebruary 14, 2025
Main results expectedJanuary 2027
Study endsDecember 2030
Registry record updatedJuly 20, 2026
Trial IDNCT06284655 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a confirmed ADHD diagnosis who speak a Scandinavian language, are treated as outpatients at participating CMHCs, and are willing and able to give informed consent.

Probably not a fit

People who cannot give informed consent, are currently admitted to acute psychiatric wards, have severe learning difficulties, do not speak a Scandinavian language, or are enrolled in other research may not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares a brief, group-based educational intervention co-developed with user representatives plus standard outpatient care to standard care alone for adults with ADHD in community mental health centres. The intervention combines group sessions and digital support tools and is delivered at participating CMHCs (led from St. Olav's Hospital) to outpatients who speak a Scandinavian language. Primary outcomes include patient satisfaction with treatment and information, general self-efficacy, and patient activation, analyzed using an intention-to-treat approach. Eligible participants have a confirmed ADHD diagnosis and are able to give informed consent, while those with severe learning difficulties or currently admitted to acute inpatient wards are excluded.

Why it matters

Potential benefit: If successful, the program could increase patient engagement, self-efficacy, and satisfaction with care, helping people manage ADHD more effectively within routine outpatient services.

How similar studies have gone: Educational and self-management programs have shown moderate benefits for patient satisfaction and activation in other mental health settings, but brief group psychoeducation specifically tailored for adults with ADHD remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed ADHD-diagnosis
* Speaking a Scandinavian language
* Willing to participate

Exclusion Criteria:

* Unable to give informed consent
* In-patient on a acute psychiatric ward
* Severe learning difficulties
* Involvement in other research studies

Where it's running

  • St Olav's Hospital
    Trondheim, Norway
    Recruiting

Study contacts

  • Principal investigator: Mariela Loreto Lara-Cabrera, PhD — Norwegian University of Science and Technology
  • Study coordinator: Mariela Loreto Lara-Cabrera, PhD
  • Email: mariela.lara@ntnu.no
  • Phone: +4748280188

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.